In particular, the role of the PARK2 gene, a variant of which, the p.Arg402Cys, has been shown to be enriched as much in our cohort of patients with ALS as in a cohort of patients with FTD previously, is intriguing. The gene discussed is PRKN; the disease is amyotrophic lateral sclerosis.